AI-generated summary
The authors report a randomized clinical study of 30 oncology patients with oral mucositis, comparing nystatin, low-level laser photobiomodulation, and curcumin-based antimicrobial photodynamic therapy with blue LED light. They describe reduced mucositis degree and pain scores in the photobiomodulation and photodynamic groups, with the photodynamic group showing earlier improvement and greater Candida reduction.
- Participants
- 30
- Who or what was studied
- Oncology patients over 18 years old with stable oral mucosa lesions undergoing chemotherapy and/or radiotherapy
- Wavelengths
- 450 nm
- Limits stated in the abstract
- The study was conducted at a single location with a small sample of 30 patients divided into three groups.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oral mucositis, Photodynamic therapy, Control group, Light-emitting diode, Low-level laser therapy, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.